INDO US BIOTECH   
                    
                    
                                                     
                                
                                                                 Back to All Ratios 
                                                
                     | 
                        
                        
                        
                        
                    
INDO US BIOTECH Last 5 Year EV/Net Sales History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EV/Net Sales(x) | 2.98 | 6.29 | 3.64 | 1.48 | 0.78 | 
What is the latest EV/Net Sales ratio of INDO US BIOTECH ?
| Year | EV/Net Sales | 
|---|---|
| Mar2025 | 2.98 | 
| Mar2024 | 6.29 | 
| Mar2023 | 3.64 | 
| Mar2022 | 1.48 | 
| Mar2021 | 0.78 | 
How is EV/Net Sales of INDO US BIOTECH Trending?
| Years | EV/Net Sales | % Change | |
|---|---|---|---|
| Mar2025 | 2.98 | -52.62 | |
| Mar2024 | 6.29 | 72.80 | |
| Mar2023 | 3.64 | 145.95 | |
| Mar2022 | 1.48 | 89.74 | |
| Mar2021 | 0.78 | - | |
Other Financial Ratios of INDO US BIOTECH
| Operational &  Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate  | Margin  Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin  | Performance  Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales  | Efficiency  Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days  | Valuation  Parameters PER PCE Price/Book Yield EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales  | Growth  Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth  | Financial Stability  Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap  | 
Compare EV/Net Sales ratio of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹275.4 Cr | -3.5% | -2.9% | -41.8% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹13,816.6 Cr | -1.3% | 9.8% | -28% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,304.9 Cr | -1.1% | -2.5% | 22.6% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,159.5 Cr | 5.2% | 2.5% | -11.7% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,296.7 Cr | -0.6% | -2.7% | -23.8% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹465.0 Cr | -5.6% | -17.8% | 21.3% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| INDO US BIOTECH |    -3.5%  | 
                            
                     
                     -2.9%  | 
                     
                     -41.8%  | 
                    
| SENSEX |    -0.9%  |    
                      
                    
                     4.6%  | 
                     
                     5%  | 
                    
You may also like the below Video Courses